http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3029460-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate | 2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4c5080397c4781fe7d8b45c1752216a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d115b5b631ed43689443359e99c1a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42579b840ee248d7ee862dee64f54b3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f5f50c49832c92504f9fbd4a79ae1b6 |
publicationDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-3029460-A1 |
titleOfInvention | O-cadherin as a biomarker for circulating tumor cells |
abstract | Provided are methods for detecting circulating tumor cells (CTCs) in a subject. The methods may include detecting the expression of at least one epithelial mesenchymal transition (EMT) biomarker. Further provided are kits for detecting CTCs. The kits may include antibodies to at least one EMT biomarker. Further provided are methods of predicting the responsiveness of a subject to a cancer drug, methods of targeting delivery of a cancer drug in a subject, methods of providing a cancer prognosis to a subject, and methods for following the progress of cancer in a subject. All of these methods and kits are based on the use of O-Cadherin as a biomarker for CTCs. |
priorityDate | 2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 829.